Silencing of WNK2 is associated with upregulation of MMP2 and JNK in gliomas
Citations Over Time
Abstract
Matrix metalloproteinases (MMPs) are proteolytic enzymes that degrade extracellular matrix (ECM), thus assisting invasion. Upregulation of MMPs, frequently reported in gliomas, is associated with aggressive behavior. WNK2 is a tumor suppressor gene expressed in normal brain, and silenced by promoter methylation in gliomas. Patients without WNK2 exhibited poor prognosis, and its downregulation was associated with increased glioma cell invasion. Here we showed that MMP2 expression and activity are increased in glioma cell lines that do not express WNK2. Also, WNK2 inhibited JNK, a process associated with decreasing levels of MMP2. Thus, WNK2 promoter methylation and silencing in gliomas is associated with increased JNK activation and MMP2 expression and activity, thus explaining in part tumor cell invasion potential.
Related Papers
- → Silencing LINC00294 Restores Mitochondrial Function and Inhibits Apoptosis of Glioma Cells under Hypoxia via the miR‐21‐5p/CASKIN1/cAMP Axis(2021)21 cited
- → Expression and functional implications of USP17 in glioma(2016)13 cited
- Changes in the activity of matrix metalloproteinases in regenerating rat liver after CCl4-induced injury.(2003)
- → Changes of Serum Concentrations of Matrix Metalloproteinases,Tissue Inhibitors of Metalloproteinases and Type IV Collagen in patients with various types of glomerulonephritis(種々の糸球体腎炎患者におけるMatrix Metalloproteinases,Tissue Inhibitors of Metalloproteinases,IV型コラーゲンの血清中濃度の変化)(1997)
- Dynamic expression of MMP-13,MMP-2,MT-MMP2 in reversal of experimental hepatic fibrosis in rats(2007)